NeOnc Technologies Holdings, Inc. Share Price

NeOnc Technologies Holdings, Inc. Share Price

NASDAQ: NTHI | Micro Cap
$3.12
+$0.22 (7.41%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NeOnc Technologies Holdings, Inc. Stock Performance

Open
$3.00
Prev. Close
$2.90
Circuit Range
N/A
Day Range
$3.00 - $3.15
Year Range
$2.52 - $11.88
Volume
3,935
Average Traded
$3.09

NeOnc Technologies Holdings, Inc. Share Price Today

As of 30 October 2026, NeOnc Technologies Holdings, Inc.'s share price is $3.12. The stock opened at $3.00, compared to its previous close of $2.90. During today's trading session, NeOnc Technologies Holdings, Inc.'s share price traded between $3.00 and $3.15, with an average price of $3.08. Over the past 52 weeks, the stock has recorded a high of $11.88 and a low of $2.52. In terms of performance, NeOnc Technologies Holdings, Inc.'s share price has declined by 28.64% over the last six months and is down 69.82% on a year-on-year basis.

NeOnc Technologies Holdings, Inc. Share Price Chart

Line chart of the NeOnc Technologies Holdings, Inc. price trend over the selected period. The price rose overall, ranging from 3.00 to 3.16, ending at 3.12.
$3.00$3.15
L
Show Current Price
H

NeOnc Technologies Holdings, Inc. Stock Fundamentals & Key Indicators

Market Cap
$60.43M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.64
Revenue (TTM)
$40.00M
Return On Equity (TTM)
254.73%
Profit Margin
-155375.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-65.20%

NeOnc Technologies Holdings, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.62-$15.52-$8.82-$14.24
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-80.05%43.17%-61.45%

NeOnc Technologies Holdings, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.04
Net Profit-$62.15
Net Profit Margin-155375.00%
Income ChangeN/A

About NeOnc Technologies Holdings, Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

NeOnc Technologies Holdings, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$3.25
$3.10
-9.36%
Sep 2026
$4.89
$3.42
-25.81%
Aug 2026
$3.54
$4.61
+31.34%
Jul 2026
$4.48
$3.51
-21.65%
Jun 2026
$4.52
$4.48
-4.27%
May 2026
$4.36
$4.68
+7.22%
Apr 2026
$6.59
$4.37
-37.64%
Mar 2026
$9.96
$7.00
-31.51%
Feb 2026
$9.40
$10.22
+9.48%
Jan 2026
$8.91
$9.34
+10.34%
Dec 2025
$8.65
$8.46
-6.73%
Nov 2025
$10.45
$9.07
-12.11%

NTHI Share Price FAQs